Association between preprocedural hemoglobin level and 1-year outcome of elective percutaneous coronary intervention

Journal of Cardiovascular Medicine

Volumn 15, Issue 4, 2014, Pages 331-335

  Hosseini, Seyed Kianoosh ^a   Ansari, Mohammad Javad Alemzadeh ^a   Lotfi Tokaldany, Masoumeh ^a   Sharafi, Ahmad ^a   Hakki Kazazi, Elham ^a   Poorhosseini, Hamidreza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

anemia; hemoglobin; percutaneous coronary intervention

Indexed keywords

CREATININE; HEMOGLOBIN;

ADULT; ANEMIA; ARTICLE; BARE METAL STENT; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; CREATININE CLEARANCE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART DEATH; HEART DISEASE; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION; SMOKING; TARGET LESION REVASCULARIZATION; TREATMENT OUTCOME; AGED; BLOOD; COMPLICATION; EPIDEMIOLOGY; IRAN; KAPLAN MEIER METHOD; MIDDLE AGED; MYOCARDIAL INFARCTION; PREOPERATIVE PERIOD; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; ANEMIA; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; IRAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PREOPERATIVE PERIOD; SEVERITY OF ILLNESS INDEX;

EID: 84898421094     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32835ec938     Document Type: Article

References (25)

1. Boden WE, Shah PK, Gupta V, Ohman EM. Contemporary approach to the diagnosis and management of non-ST-segment elevation acute coronary syndromes. Prog Cardiovasc Dis 2008; 50:311-351
2. Turpie AG. Burden of disease: medical and economic impact of acute coronary syndromes. Am J Manag Care 2006; 12 (Suppl 16):S430-S434
3. Hatmi ZN, Tahvildari S, Ghafarzadeh Motlag A, Sabouri Kasnani A. Prevalence of coronary artery disease risk factor in Iran: a population based survey. BMC Cardiovasc Disord 2007; 7:32
4. Hoseini SK, Sadeghian S, Mahmoudian M, et al. Family history of cardiovascular disease as a risk factor for coronary artery disease in adult offspring. Monaldi Arch Chest Dis 2008; 70:84-87
5. Dauerman HL, Lessard D, Yarzebski J, et al. Bleeding complications in patients with anemia and acute myocardial infarction. Am J Cardiol 2005; 96:1379-1383
6. Androne AS, Katz SD, Lund L, et al. Hemodilution is common in patients with advanced heart failure. Circulation 2003; 107:226-229
7. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12,065 patients with new-onset heart failure. Circulation 2003; 107:223-225
8. Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996; 348:1055-1060
9. Carrascal Y, Maroto L, Rey J, et al. Impact of preoperative anemia on cardiac surgery in octogenarians. Interact Cardiovasc Thorac Surg 2010; 10:249-255
10. Kulier A, Levin J, Moser R, et al. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Investigators of the Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation. Circulation 2007; 116:471-479
11. Nikolsky E, Aymong ED, Halkin A, et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol 2004; 44:547-553
12. Voeltz MD, Patel AD, Feit F, et al. Effect of anemia on hemorrhagic complications and mortality following percutaneous coronary intervention. Am J Cardiol 2007; 99:1513-1517
13. Bolin ska S, Sobkowicz B, Zaniewska J, et al. The significance of anaemia in patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Kardiol Pol 2011; 69:33-39
14. Reinecke H, Trey T, Wellmann J, et al. Haemoglobin-related mortality in patients undergoing percutaneous coronary interventions. Eur Heart J 2003; 24:2142-2150
15. Lee PC, Kini AS, Ahsan C, et al. Anemia is an independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol 2004; 44:541-546
16. McKechnie RS, Smith D, Montoye C, et al. Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention. Circulation 2004; 110:271-277
17. World Health Organization. Nutritional anaemias: report of a WHO scientific group. World Health Organ Tech Rep Ser 1968; 405:33-37
18. Alidoosti M, Salarifar M, Haji-Zeinali AM, et al. Clinical outcomes of drugeluting stents compared with bare metal stents in our routine clinical practice. Hellenic J Cardiol 2008; 49:132-138
19. Kassaian SE, Sahebjam M, Salarifar M, et al. Predictors of long-term outcome in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A single center registry. J Tehran Heart Center 2006; 3:155-161
20. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinin. Nephron 1976; 16:31-41
21. Anonymous. Executive summary: K/DOQI clinical practice guidelines. Am J Kidney Dis 2002; 39:S17-S31
22. Sarnak MJ, Tighiouart H, Manjunath G, et al. Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol 2002; 40:27-33
23. Gagnon DR, Zhang TJ, Brand FN. Hematocrit and the risk of cardiovascular disease - the Framingham study: a 34-year follow-up. Am Heart J 1994; 127:674-682
24. Pilgrim T, Vetterli F, Kalesan B, et al. The impact of anemia on long-term clinical outcome in patients undergoing revascularization with the unrestricted use of drug-eluting stents. Circ Cardiovasc Interv 2012; 5:202-210
25. Myojo M, Iwata H, Kohro T, et al. Prognostic implication of macrocytosis on adverse outcomes after coronary intervention. Atherosclerosis 2012; 221:148-153.